Stockreport

Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science [Read more]